Skip to main content

Advertisement

Log in

Parathyroid function in end-stage penal failure

  • Section III: Symposium II Renal Osteopathy October 30, 1992, Osaka
  • Published:
Journal of Bone and Mineral Metabolism Aims and scope Submit manuscript

Abstract

To clarify the degree of parathyroid dysfunction in end-stage renal failure, sigmoidal relationship between serum Ca2+ and intact-PTH was evaluated in vivo in 47 hemodialysis (HD) patients including 12 diabetics. Patients were divided into 3 groups, 9 who had been just introduced to HD (0 years), 31 who were on maintenance HD for 2.5 to 16.2 years without significant secondary hyperparathyroidism (2nd HPT), and 7 who suffered from severe 2nd HPT for 8.5 to 15.3 years on HD. Additional 4 patients who were treated with HD or hemodiafiltration because of acute hepatic failure with normal renal function were selected for control. Sigmoidal curve (SC) in patients with non-diabetics on 0 years on HD was significantly deviated to upper and right direction. Similarly, the set point of calcium (SP) in non-diabetics was deviated to the right (higher calcium level). These abnormalities were more pronounced as the length of HD duration increased. However, these parathyroid dysfunction was not obvious in diabetic patients. In severe 2nd HPT, SC and SP were remarkably deranged. Mean SP in these patients was 1.22 mmol/l, and 1.26 mmol/l in 3 patients who required parathyroidectomy after the study. These results indicate that the earlier treatment to prevent 2nd HPT would be necessary from conservative stage of renal failure in non-diabetic population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Brown EM, Wilson RE, Eastman RC, et al. Abnormal regulation of parathyroid hormone release by calcium in secondary hyperparathyroidism due to chronic renal faiure. J Clin Endocrinol Metab 54: 172–179, 1982

    CAS  PubMed  Google Scholar 

  2. Birnbaumer M, Schneider A, Palmer D, et al. Secretion of parathyroid hormone by abnormal human parathyroid glands in vitro. J Clin Endocrilol Metab 45: 105–113, 1977

    CAS  Google Scholar 

  3. Brown EM. Four-parameter model of the sigmoidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue. J Clin Endocrinol Metab 56: 572–581, 1983

    CAS  PubMed  Google Scholar 

  4. Dunlay R, Rodrigues M, Felsenfeld AJ, et al. Direct inhibitory effect of parathyroid function (sigmoidal curve) in dialysis. Kidney Int 36: 1093–1098, 1989

    CAS  PubMed  Google Scholar 

  5. Slatopolsky E, Weerts C, Thielan J, et al. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients. J Clin Invest 74: 2136–2143, 1984

    CAS  PubMed  Google Scholar 

  6. Tsukamoto Y, Nomura Y, Takahashi Y, et al. The oral 1,25-dihydroxy vitamin D3 pulse therapy in hemodialysis patients with severe secondary hyperparathyroidism. Nephron 57: 23–28, 1991

    CAS  PubMed  Google Scholar 

  7. Akizawa T, Koshikawa S, Ogura Y, et al. Oral puse of 1α OHD suppresses PTH in refractory patients with secondary hyperparathyroidism (abstract). Proceedings, Singapore symposium on renal blood disease, July 1990

  8. Pabico RC, Rivero AJ, Mckenna AB, et al. Parathyroid hormone in patients with diabetes mellitus and end-stage renal disease on chronic hemodialysis. Proc EDTA, 221–226, 1982

  9. McNair P, Christensen MS, Madsbad S, et al. Hypoparathyroidism in diabetes mellitus. Acta Endocrinol 96: 81–86, 1981

    CAS  PubMed  Google Scholar 

  10. Morrisey J, Rothstein M, Slatopolsky E, et al. Suppression of parathyroid hormone secretion by aluminum. Kidney Int 23: 699–704, 1983.

    Google Scholar 

  11. Sugimoto T, Ritter C, Morrisey J, et al. Effects of high concentration of glucose on PTH secretion in parathyroid cells. Kidney Int 37: 1522–1527, 1990

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Kinugasa, E., Akizawa, T. & Koshikawa, S. Parathyroid function in end-stage penal failure. J Bone Miner Metab 11, S53–S58 (1993). https://doi.org/10.1007/BF02383844

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02383844

Key words

Navigation